Connecting Australia’s chemistry researchers with the global bioscience research community.
Compounds Australia provides access to critical infrastructure and expertise to ensure flexible, efficient, reproducible and cost-effective compound management, supporting biological characterisation of compounds throughout the drug discovery pipeline. It manages a national ‘Open’ compound collection, and numerous ‘Closed’ or proprietary compound collections.
Compounds Australia is housed at Griffith Institute of Drug Discovery (GRIDD). GRIDD researchers tackle devastating diseases using Compounds Australia and other unique resources including NatureBank, Australia's largest natural product bio-discovery library stored at Compounds Australia.
Compounds Australia is actively supported by Griffith University through ongoing financial contributions to ensure that an essential piece of Australia's NCRIS infrastructure is made available to global researchers and industry.
Compounds Australia is part of the National Collaborative Research Infrastructure Strategy (NCRIS), a national network of world-class research infrastructure projects that support high-quality research to drive greater innovation in the Australian research sector and the economy more broadly.
Queensland acoustic compound support could help COVID-19 breakthroughs
05 Jun 2020
The Queensland Government has awarded $1.875 million in funding to Compounds Australia.
GRIDD researchers take next step in COVID-19 vaccine development
30 Mar 2020
Scientists at Griffith University are moving towards animal trials in testing a vaccine candidate...
Griffith awarded $3.3 million in funding for ARC Discovery and Linkage projects
05 Dec 2019
Griffith University has been awarded $3,376,073 for ARC Discovery and Linkage Projects.
Acoustic tech grant a win for Griffith biomedical research
18 Sep 2019
Grant to fund technology that uses sound waves to vibrate chemical samples from acoustic microtube...